Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Barjon

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Pharmacy and Pharmacology|May 1, 1978
Contribution of prostaglandins to the vasodepressor effect of dopamine in the ratC Chevillard, M N Mathieu, P Barjon
Clinical Science and Molecular Medicine. Supplement|June 1, 1975
Effect of a competitive angiotensin antagonist on the renal haemodynamic changes induced by inhibition of prostaglandin synthesis in ratsA Mimran, D Casellas, M Dupont, et al.
Kidney International|January 1, 1973
A dye-dilution cardiac output technique for hemodialyzed patients with arteriovenous fistulaB Charra, G Huchard, C Mion, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1979
[Saralasin and prediction of the surgical result in renovascular arterial hypertension]A Mimran, G Deschodt, J Fourcade, et al.
La Vie Medicale Au Canada Francais|September 1, 1972
[Determination of glomerular filtration by radioactive iothalamate: comparison of continuous perfusion and single rapid injection methods]J Mirouze, P Barjon, L Monnier, et al.
Clinical Nephrology|February 1, 1978
The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patientsA Mimran, S Shaldon, P Barjon, et al.
Nephrologie|January 1, 1982
[Reversible acute renal failure and nephrotic syndrome induced by fenoprofene ]G Mourad, A Mimran, P Baldet, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1979
The renin-angiotensin system and the antihypertensive effect of atenolol in manA Mimran, G Deschodt, J Fourcade, et al.
Revue Europeenne D'Etudes Cliniques Et Biologiques. European Journal of Clinical and Biological Research|February 1, 1972
Paroxysmal hypertension during L-dopa treatment in parkinsonism: a metabolic error or a pharmacological effect?P Barjon, J Fourcade, A Mimran, et al.
Le Poumon Et Le Coeur|January 1, 1971
[Schwartz-Bartter syndrome]P Barjon, H Mion, F B Michel, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Pharmacy and Pharmacology|May 1, 1978
Contribution of prostaglandins to the vasodepressor effect of dopamine in the ratC Chevillard, M N Mathieu, P Barjon
Clinical Science and Molecular Medicine. Supplement|June 1, 1975
Effect of a competitive angiotensin antagonist on the renal haemodynamic changes induced by inhibition of prostaglandin synthesis in ratsA Mimran, D Casellas, M Dupont, et al.
Kidney International|January 1, 1973
A dye-dilution cardiac output technique for hemodialyzed patients with arteriovenous fistulaB Charra, G Huchard, C Mion, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1979
[Saralasin and prediction of the surgical result in renovascular arterial hypertension]A Mimran, G Deschodt, J Fourcade, et al.
La Vie Medicale Au Canada Francais|September 1, 1972
[Determination of glomerular filtration by radioactive iothalamate: comparison of continuous perfusion and single rapid injection methods]J Mirouze, P Barjon, L Monnier, et al.
Clinical Nephrology|February 1, 1978
The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patientsA Mimran, S Shaldon, P Barjon, et al.
Nephrologie|January 1, 1982
[Reversible acute renal failure and nephrotic syndrome induced by fenoprofene ]G Mourad, A Mimran, P Baldet, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1979
The renin-angiotensin system and the antihypertensive effect of atenolol in manA Mimran, G Deschodt, J Fourcade, et al.
Revue Europeenne D'Etudes Cliniques Et Biologiques. European Journal of Clinical and Biological Research|February 1, 1972
Paroxysmal hypertension during L-dopa treatment in parkinsonism: a metabolic error or a pharmacological effect?P Barjon, J Fourcade, A Mimran, et al.
Le Poumon Et Le Coeur|January 1, 1971
[Schwartz-Bartter syndrome]P Barjon, H Mion, F B Michel, et al.
Pageof 5